CIK 0001855175
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Contineum Therapeutics, Inc.
Sign in to watch- Ticker
- CTNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271467257
- Phone
- +1 858-333-5280
- Business address
- 3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,142
- in 1 filing, $41K under 10b5-1 plans
Net −$41,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-30 | Watkins Tim CMO & Head of Development | Option exercise 10b5-1 | +10,833 | $4.50 | $49K | 19,794 |
| 2026-06-30 | Watkins Tim CMO & Head of Development | Sale 10b5-1 | −10,833 | $16.02 | $174K | 8,961 |
| 2026-06-30 | Watkins Tim CMO & Head of Development | Option exercise · Stock Option (right to buy) 10b5-1 | −10,833 | 238,334 | ||
| 2026-03-02 | Watkins Tim CMO & Head of Development | Option exercise 10b5-1 | +3,611 | $4.50 | $16K | 3,611 |
| 2026-03-02 | Watkins Tim CMO & Head of Development | Sale 10b5-1 | −3,611 | $15.02 | $54K | 0 |
| 2026-03-02 | Watkins Tim CMO & Head of Development | Option exercise · Stock Option (right to buy) 10b5-1 | −3,611 | 249,167 | ||
| 2026-01-30 | Watkins Tim CMO & Head of Development | Grant or award · Stock Option (right to buy) 10b5-1 | +160,000 | 160,000 | ||
| 2026-01-28 | Watkins Tim CMO & Head of Development | Option exercise 10b5-1 | +3,611 | $4.50 | $16K | 3,611 |
| 2026-01-28 | Watkins Tim CMO & Head of Development | Sale 10b5-1 | −2,800 | $14.09 | $39K | 811 |
| 2026-01-28 | Watkins Tim CMO & Head of Development | Sale 10b5-1 | −811 | $14.48 | $12K | 0 |
| 2026-01-28 | Watkins Tim CMO & Head of Development | Option exercise · Stock Option (right to buy) 10b5-1 | −3,611 | 252,778 | ||
| 2025-12-29 | Watkins Tim CMO & Head of Development | Option exercise 10b5-1 | +3,611 | $4.50 | $16K | 3,611 |
| 2025-12-29 | Watkins Tim CMO & Head of Development | Sale 10b5-1 | −3,611 | $12.06 | $44K | 0 |
| 2025-12-29 | Watkins Tim CMO & Head of Development | Option exercise · Stock Option (right to buy) 10b5-1 | −3,611 | 256,389 | ||
| 2025-04-28 | Watkins Tim CMO & Head of Development | Grant or award · Stock Option (right to buy) | +260,000 | 260,000 | ||
| 2025-04-28 | Watkins Tim CMO & Head of Development | Grant or award · Stock Option (right to buy) | +26,000 | 26,000 |
Page 1 of 1 · 16 trades